SCHEMBL29133711

SCHEMBL29133711

CCC1(Nc2ncnc3ccc(-c4cncc(N(S(C)(=O)=O)S(C)(=O)=O)c4)cc23)C=CC=CC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 2/20 0.41
▸ EGFR P00533 2/20 0.41
▸ IRAK4 Q9NWZ3 11/20 0.38
▸ MAPK10 P53779 1/20 0.36
▸ BRAF P15056 1/20 0.35
▸ CYP1A2 P05177 3/20 0.35
▸ CYP3A4 P08684 3/20 0.35
▸ CYP2D6 P10635 3/20 0.35
▸ HPGD P15428 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ USP2 O75604 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CLK4 Q9HAZ1 1/20 0.34
▸ PIK3C3 Q8NEB9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29133764 0.86 PIK3CA (0.37) PIK3CAEGFRIRAK4BRAFCYP1A2
SCHEMBL29133759 0.86 EGFR (0.57) PIK3CAEGFRBRAFCYP1A2CYP3A4
SCHEMBL29133774 0.83 IRAK4 (0.47) PIK3CAEGFRIRAK4CYP1A2CYP3A4
SCHEMBL29133704 0.81 IRAK4 (0.54) PIK3CAEGFRIRAK4CYP1A2CYP3A4
SCHEMBL29133754 0.80 IRAK4 (0.51) PIK3CAEGFRIRAK4CLK4
SCHEMBL29133748 0.80 EGFR (0.47) PIK3CAEGFRCYP1A2CYP3A4CYP2D6
SCHEMBL29133776 0.79 EGFR (0.58) PIK3CAEGFR
SCHEMBL29133728 0.79 IRAK4 (0.48) EGFRIRAK4CYP1A2CYP3A4CYP2D6
SCHEMBL29133716 0.77 IRAK4 (0.39) EGFRIRAK4CYP1A2CYP3A4CYP2D6
SCHEMBL29133742 0.77 IRAK4 (0.35) PIK3CAIRAK4BRAFCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295716-A Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors 麦克尼斯迪克治疗有限公司 2023-12-26 — — CN disclosed
Send feedback